Verici Dx plc (AIM:VRCI)
0.7000
0.00 (0.00%)
Oct 31, 2025, 3:29 PM GMT+1
Verici Dx Revenue
Verici Dx had revenue of $1.91M USD in the half year ending June 30, 2025, with 9,968.42% growth. This brings the company's revenue in the last twelve months to $1.91M, down -55.85% year-over-year. In the year 2024, Verici Dx had annual revenue of $3.34M with 229.62% growth.
Revenue (ttm)
$1.91M
Revenue Growth
-55.85%
P/S Ratio
7.59
Revenue / Employee
$106.28K
Employees
18
Market Cap
10.59M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.34M | 2.33M | 229.62% |
| Dec 31, 2023 | 1.01M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
Verici Dx News
- 26 days ago - Verici Dx Plc (VRCDF) Interim Results Investor Presentation Call Transcript - Seeking Alpha
- 26 days ago - Verici Dx plc - Special Call - Seeking Alpha
- 6 months ago - AIM Market Roundup: Belluscura, Tiger Royalties, ITM Power - The Armchair Trader
- 7 months ago - AIM Market Roundup: Ethernity Networks, Verici DX, Aferian - The Armchair Trader
- 7 months ago - AIM Market Roundup: Rome Resources, Celadon Pharmaceuticals, Churchill China - The Armchair Trader
- 7 months ago - AIM Market Roundup: Celadon Pharma, Oracle Power, Volex - The Armchair Trader
- 11 months ago - FBB Biomed Signs Agreement with Verici Dx plc to Offer Research-Use-Only “RUO” Tests to Clinicians - Business Wire